OPGN stock forecast
Our latest prediction for OpGen, Inc.'s stock price was made on the Nov. 11, 2019 when the stock price was at 1.32$.
In the short term (2weeks), OPGN's stock price should outperform the market by 0.69%. During that period the price should oscillate between -13.67% and +42.52%.
In the medium term (3months), OPGN's stock price should outperform the market by 3.21%. During that period the price should oscillate between -28.00% and +118.04%.
Get email alertsAbout OpGen, Inc.
OpGen, Inc. engages in the development of molecular information products and services for global healthcare settings. It helps to guide clinicians with more rapid and actionable information about life threatening infections, improve patient outcomes, and decrease the spread of infections caused by multidrug-resistant microorganisms (MDROs). The company was founded on January 22, 2001 and is headquartered in Gaithersburg, MD.
At the moment the company generates 3M USD in revenues.
On its last earning announcement, the company reported a loss of -28.20$ per share.
The book value per share is 1.03$
Three months stock forecastNov. 11, 2019
Financials
| Revenue USD | Gross Margin | Operating Income | Operating Margin | Net Income | Earnings Per Share | Dividends | Payout Ratio | Shares | Book Value Per Share | Operating Cash Flow | Cap Spending | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3M | 50.00% | -13M | -381.10% | -13M | -28.20 | - | - | 1M | 1.03 | -11M | - | -12M |